(Q47689922)

4 February 2018

title

Estimation of CYP2D6*10 genotypes on citalopram disposition in Chinese subjects by population pharmacokinetic assay (English)

1 reference

4 February 2018

1 reference

B Chen

1

1 reference

4 February 2018

Y Xu

2

1 reference

4 February 2018

T Jiang

3

1 reference

4 February 2018

R Feng

4

1 reference

4 February 2018

J Sun

5

1 reference

4 February 2018

W Zhang

6

1 reference

4 February 2018

W Yang

7

1 reference

4 February 2018

J Li

8

1 reference

4 February 2018

O Adeniyi

9

1 reference

4 February 2018

H Chen

10

1 reference

4 February 2018

publication date

28 August 2013

1 reference

4 February 2018

Journal of Clinical Pharmacy and Therapeutics

published in

1 reference

4 February 2018

volume

38

1 reference

4 February 2018

issue

6

1 reference

4 February 2018

page(s)

504-511

1 reference

4 February 2018

Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

The effect of age and concomitant treatment with other psychoactive drugs on serum concentrations of citalopram measured with a nonenantioselective method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

Frequency of human CYP2D6 mutant alleles in a normal Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

Simultaneous determination of citalopram and its metabolite in human plasma by LC-MS/MS applied to pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

The utility of the population approach applied to bioequivalence in patients: comparison of 2 formulations of cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12029

21 January 2018

Identifiers

DOI

10.1111/JCPT.12029

1 reference

4 February 2018

1 reference

4 February 2018